Stock Price
1,513.00
Daily Change
11.35 0.76%
Monthly
10.62%
Yearly
26.96%
Q2 Forecast
1,478.96

Aurobindo Pharma reported INR12.43B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Cipla INR 6.14B 3.63B Mar/2026
Divis Laboratories Ltd INR 7.72B 30M Dec/2025
Dr.Reddys Laboratories INR 888M 13.05B Mar/2026
Hindustan Unilever INR 33.49B 1.02B Mar/2026
Sun Pharmaceuticals INR 40.62B 6.95B Dec/2025
UPL INR 27.32B 11.26B Mar/2026